CorMedix competitorsClear all

CorMedix's top competitors include Alexion Pharmaceuticals, Veloxis Pharmaceuticals and ASIT Biotech.
CorMedix
CorMedix
CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease.
Alexion Pharmaceuticals
Alexion Pharmaceuticals
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.
Veloxis Pharmaceuticals
Veloxis Pharmaceuticals
Veloxis Pharmaceuticals is a biopharmaceutical company, which identifies, develops, and commercializes products that are used in transplantation and adjacent therapies.
ASIT Biotech
ASIT Biotech
ASIT Biotech is a clinical-stage biopharmaceutical company, which focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies.
Founding Date
Founding Date
2006
Founding Date
1992
Founding Date
2002
Founding Date
1997
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Bedminster Township, US HQ
Locations
New Haven, US HQ
Buenos Aires, AR
Sydney, AU
Vienna, AT
São Paulo, BR
Toronto, CA
Prague, CZ
see more
Locations
København, DK HQ
Locations
Sint-Lambrechts-Woluwe, BE HQ
Employees
Employees
2257% increase
Employees
2,6565% increase
Employees
54
Employees
2630% increase
Valuation ($)
Valuation ($)
176.2 m
Valuation ($)
26.1 b
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
641
Twitter followers
3.8 k
Twitter followers
N/A
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
915620
Alexa Website Rank
628049
Alexa Website Rank
351865
Alexa Website Rank
477702

Financial

Revenue (est.)
Revenue (est.)
$429.8k (FY, 2018)
Revenue (est.)
$3.1b (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
$396.8k (FY, 2018)
Cost of goods
$258m (FY, 2016)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$33k (FY, 2018)
Gross profit
$2.8b (FY, 2016)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($26.8m) (FY, 2018)
Net income
$399m (FY, 2016)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 11.5m
Total funding raised
N/A
Total funding raised
$ 60m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Alexion Pharmaceuticals
HQ
New Haven, US
Employees
2,656↑ 5% increase

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.

View company
Veloxis Pharmaceuticals
HQ
København, DK
Employees
54

Veloxis Pharmaceuticals is a biopharmaceutical company, which identifies, develops, and commercializes products that are used in transplantation and adjacent therapies.

View company
ASIT Biotech
HQ
Sint-Lambrechts-Woluwe, BE
Employees
26↑ 30% increase

ASIT Biotech is a clinical-stage biopharmaceutical company, which focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies.

View company